Extended interval dosing of natalizumab in multiple sclerosis.
about
A link between long-term natalizumab dosing in MS and PML: Putting the puzzle togetherThe use of natalizumab for multiple sclerosisSafety of monoclonal antibodies for the treatment of multiple sclerosis.New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing.Exposure-disease response analysis of natalizumab in subjects with multiple sclerosis.The role of natalizumab in the treatment of multiple sclerosis: benefits and risks.John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients.Reducing costs while enhancing quality of care in MS.Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.Prediction of natalizumab anti-drug antibodies persistency.Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.Identification of Peptide Mimotope Ligands for Natalizumab
P2860
Q33363188-3ABDA3AB-13D5-4B26-A05E-EB0638F3A2AAQ33879159-B0DA2954-B36A-47AA-ACE2-E5E7006524C9Q34542922-02C67254-12C3-49E1-9737-4967ACA9C223Q37045253-172AD55E-D226-46F8-966C-7C83791D59DCQ38796218-DE456A3D-26F5-428A-A53C-AC59EEDD042BQ38934396-CE09EE8B-8605-4141-B426-A9BE401130E7Q40061894-1C5D3D7F-0DE4-4FA4-8D85-588C4277C80BQ40122994-8740C8B5-3C6E-4B4A-9143-2DCEEF2479CDQ41966640-0EE0270C-D14A-4704-B1B6-CFE3771A97B4Q42266048-E46E1172-9E1A-40CA-95FF-EFA78D705C14Q48237799-721839A9-C353-4306-ADB5-7C0A09CB83BCQ48664001-AC7B5E7C-0A2B-4F9C-9A70-5D9EB80A57B4Q56876832-89B2A4F6-BE9C-4DA7-9279-5A7816E9C6D9
P2860
Extended interval dosing of natalizumab in multiple sclerosis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Extended interval dosing of natalizumab in multiple sclerosis.
@ast
Extended interval dosing of natalizumab in multiple sclerosis.
@en
type
label
Extended interval dosing of natalizumab in multiple sclerosis.
@ast
Extended interval dosing of natalizumab in multiple sclerosis.
@en
prefLabel
Extended interval dosing of natalizumab in multiple sclerosis.
@ast
Extended interval dosing of natalizumab in multiple sclerosis.
@en
P2093
P2860
P356
P1476
Extended interval dosing of natalizumab in multiple sclerosis.
@en
P2093
B Weinstock-Guttman
C Tornatore
E M Frohman
P2860
P304
P356
10.1136/JNNP-2015-312940
P407
P577
2016-02-25T00:00:00Z